Physician profile
Shelley E Justa
NPI 1881778694
$979.36
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $138 · 2022: $162.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $139.11 | 2019-2022 | |
| Novo Nordisk INC | $122.62 | 2019-2022 | |
| Amgen INC. | $92.51 | 2019 | |
| Janssen Pharmaceuticals, INC | $66.62 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.37 | 2019-2020 | |
| Abbott Laboratories | $57.47 | 2022 | |
| Glaxosmithkline, LLC. | $52.85 | 2019-2020 | |
| Allergan, INC. | $51.68 | 2019-2020 | |
| Amarin Pharma, INC. | $44.84 | 2019-2020 | |
| Sanofi Pasteur INC. | $39.28 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $34.50 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $33.14 | 2019 | |
| Merck Sharp & Dohme LLC | $30.84 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.70 | 2020 | |
| Abbvie INC. | $27.44 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $24.12 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.03 | 2019 | |
| Astellas Pharma US INC | $13.78 | 2019 | |
| Pfizer INC. | $13.62 | 2019 | |
| Lilly USA, LLC | $12.02 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Justa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.